|
|
 |
|
Viewing report
|
|
|
|
Carotid Artery Angioplasty & Stenting Technology & Market Forecast
Medtech Reports, Feb 2010, Pages: 50
Carotid artery stenting (CAS) with embolic protection is currently being positioned as an alternative to vascular surgery, especially in patients considered for revascularization to prevent stroke but are also at increased risk for carotid surgery either due to medical or anatomic factors.
Abbott Vascular, Cordis, Boston Scientific, ev3, have transformed the competitive landscape of the market by bundling their carotid stents with their embolic protection devices as complete Carotid Artery Stent Systems.
The recent $500 million Invatec acquisition by Medronic will further reshape the future of this market and is a proof of large medical device firms commitment to the carotid artery angioplasty and stenting space.
With big medtech having an insatiable appetite for acquisitions in the neurovascular space, windows of opportunities are opening for innovative endovascular technology start-ups to deliver next generation devices.
Progress in technological improvements opportunities for carotid artery angioplasty and stenting are plenty and include new stent designs, more effective embolic protection, direct carotid access techniques, drug eluting stents (DES), drug eluting balloons (DEB), flow reversal devices, less invasive and more specific imaging & visualization technologies for better patient selection and techniques to enhance our ability to understand carotid plaque composition and morphology.
The Carotid Artery Angioplasty & Stenting - Technology & Market Forecast report offers an overview of the state of both the technology and the market. It profiles current market landscape for carotid artery stent systems and explores the market potential for those devices with global forecast to 2015.
The report details many pressing issues in the carotid stenting space and profiles current approved devices and the status of clinical development of potential new entrants.
Report Highlights:
1. Current State of the Science for both carotid endarterectomy (CEA) and carotid angioplasty and stenting (CAS).
2. Recent clinical trials and their findings.
3. Epidemiology of stroke, transient ischemic attacks (TIAs), carotid stenosis and estimated number of carotid artery stenting procedures.
4. Current market for carotid artery stent systems segmented geographically.
5. Potential market for cartoid artery stent systems.
6. Leading players in the cartotid artery angioplasty & stenting space.
7. Potential new entrants.
8. Market forecast to 2015.
Carotid Artery Angioplasty & Stenting - Technology & Market Forecast Report offers a short but thorough analysis of current a global market for carotid artery stent systems. The report is targeted at busy Medtech executives scanning for windows of opportunities opening in the pre-cerebral neuro endovascular space.
Customers who bought this item also bought
Carotid Stent Systems Market Current Status & Future Outlook
Carotid Stents - Global Strategic Business Report
Neuro Stents & Thrombectomy Systems - Technology & Market Forecast
Global Embolic Protection Devices (EPD) - Market Growth Analysis, 2009-2015
Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Interventional Cardiology - Global Strategic Business Report
Carotid Stenting - Technology & Market Forecast
Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
IntraCranial Stents Market - Technology & Market Forecast
Drug-Eluting Stents - Global Strategic Business Report
|
|
|
|
